Centricity Research London Victoria

London, Ontario N6A 2C2

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Prurigo Nodularis

Studies at this site

• A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis — Stopped early
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early